Purchase this report

Retinoic Acid Receptor Gamma - Drugs In Development, 2021

Published	Pages	Publisher	Report code
Aug 2021	88	Global Markets Direct	ASDR-589456

Published: Aug 2021 - Pages : 88 - Publisher : Global Markets Direct - Report code : ASDR-589456

Retinoic Acid Receptor Alpha - Drugs In Development, 2021 Published: August, 2021 - Pages: 76 - US$ 3,500.00
Retinoic Acid Receptor (RAR) - Drugs in Development, 2021 Published: April, 2021 - Pages: 35 - US$ 3,000.00
Retinoic Acid Receptor RXR Alpha (Nuclear Receptor Subfamily 2 Group B Member 1 or Retinoid X Receptor Alpha or NR2B1 or... Published: April, 2021 - Pages: 35 - US$ 3,000.00
Retinoic Acid Receptor Gamma - Pipeline Review, H1 2020 Published: April, 2020 - Pages: 82 - US$ 3,500.00
Retinoic Acid Receptor Alpha - Pipeline Review, H1 2020 Published: April, 2020 - Pages: 76 - US$ 3,500.00
Retinoic Acid Receptor Beta - Pipeline Review, H2 2019 Published: November, 2019 - Pages: 77 - US$ 3,500.00
Retinoic Acid Receptor Gamma (RAR Gamma or Nuclear Receptor Subfamily 1 Group B Member 3 or NR1B3 or RARG) - Pipeline Re... Published: April, 2019 - Pages: 81 - US$ 3,500.00
Retinoic Acid Receptor Beta (RAR Beta or HBV Activated Protein or Nuclear Receptor Subfamily 1 Group B Member 2 or RAR E... Published: April, 2019 - Pages: 71 - US$ 3,500.00
Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B Member 1 or NR1B1 or RARA) - Pipeline Re... Published: April, 2019 - Pages: 64 - US$ 3,500.00

Mark your calendar:

Medical Science Liaison (MSL) Best Practices Summit

14 September - 15 September, 2022
Online, Your Computer